| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $54K | -10.0% | — |
| R&D Expense | $30K | -34.8% | -91.9% |
| SG&A Expense | $2.7M | -17.2% | +13.7% |
| Operating Income | -$21.6M | +27.6% | -679.0% |
| Net Income | -$23.7M | +23.1% | -820.9% |
| EPS (Basic) | -$0.66 | +19.5% | -69.2% |
| EPS (Diluted) | -$0.66 | +19.5% | -69.2% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $7.5M | -13.9% | -63.1% |
| Current Assets | $11.0M | +0.6% | -47.2% |
| Total Assets | $57.8M | -30.3% | +178.1% |
| Current Liabilities | $952K | -12.4% | -23.1% |
| Total Liabilities | $952K | -12.4% | -23.1% |
| Stockholders' Equity | $56.8M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$8.0M | — | — |
| Investing Cash Flow | -$97.3M | — | — |
| Financing Cash Flow | $94.8M | — | — |
| +190.9% |